Screener
Northrop Grumman NOC Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 10.7%+0.3pp | 11.6%+2.0pp | 10.8%+0.1pp | 10.6%— | 10.4%— | |
| Net margin | 10.5%+0.7pp | 10.8%+1.6pp | 10%-0.2pp | 9.8%— | 9.7%— | |
| Returns | ||||||
| Return on equity | 27%+0.5pp | 28.5%+3.1pp | 26.2%-1.6pp | 26.2%— | 26.5%— | |
| Return on invested capital | 12.3%+0.7pp | 13.2%+2.3pp | 12.5%-0.2pp | 11.7%— | 11.6%— | |
| Efficiency | ||||||
| Asset turnover | 0.9×0.0× | 0.9×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.2×+0.1× | 1.2×+0.2× | 1.1×+0.1× | 1.1×0.0× | 1×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 1×-0.2× | 1×-0.1× | 1.1×-0.1× | 1.1×-0.1× | 1.1×-0.1× | |
| Net debt / EBITDA | 2.4×-0.4× | 2.3×-0.5× | 2.3×-0.2× | 2.7×— | 2.8×— | |
| Per Share | ||||||
| Book value per share | $125.59+16.9% | $120.11+16.1% | $115.95+11.7% | $111.41+10.7% | $107.44+11.0% | |
| Valuation | ||||||
| Market capitalization | $77.07B-8.7% | $96.82B+30.6% | $81.38B+19.0% | $87.24B+12.0% | $69.66B+7.3% | |
| Price / earnings | 17.1×-4.3× | 21.2×+1.2× | 19.5×+3.1× | 21.7×— | 17.7×— | |
| Price / sales | 1.8×-0.3× | 2.3×+0.4× | 1.9×+0.3× | 2.1×+0.2× | 1.7×+0.1× | |
| Price / book | 4.3×-1.1× | 5.7×+0.7× | 4.9×+0.4× | 5.5×+0.2× | 4.5×0.0× | |
| EV / EBITDA | 15.1×-2.9× | 17.5×+0.4× | 16×+1.4× | 17.9×— | 15.3×— | |
| Dividend yield | 1.7%+0.3pp | 1.4%-0.3pp | 1.6%-0.1pp | 1.4%-0.1pp | 1.8%0.0pp |
FAQ
- Where do Northrop Grumman's ratios come from?
- Every ratio is computed from Northrop Grumman's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
